The Growing Global Threat Of Antibiotic Resistance Ielts Reading Answers _verified_ -
Reading Time: 20 minutes Section A: A Post-Antibiotic Era? For much of human history, common infections were a death sentence. The discovery of penicillin by Alexander Fleming in 1928 heralded the golden age of antibiotics, transforming medicine and saving hundreds of millions of lives. However, in recent decades, this medical miracle has been steadily eroding. The rise of antimicrobial resistance (AMR) – specifically antibiotic resistance – is now recognised by the World Health Organization (WHO) as one of the top ten global public health threats facing humanity. Without urgent action, the world is heading towards a ‘post-antibiotic’ era, where minor injuries and routine operations could once again become fatal. Researchers warn that if current trends continue, drug-resistant infections could kill 10 million people per year by 2050, surpassing cancer as a leading cause of death. Section B: The Biological Mechanism of Resistance Antibiotic resistance is a classic example of evolution in action. When a patient takes antibiotics, the drug kills the vast majority of susceptible bacteria. However, due to random genetic mutations, a tiny fraction of bacteria may possess inherent traits that allow them to survive. These survivors multiply, passing on their resistant genes to subsequent generations. More alarmingly, bacteria can share genetic material horizontally – even between different species – through processes like conjugation and transformation. This means that resistance to one antibiotic can rapidly spread across entire bacterial populations and even jump from harmless bacteria to dangerous pathogens like Staphylococcus aureus (MRSA) or Escherichia coli . Section C: Drivers of the Global Crisis The acceleration of AMR is not accidental; it is primarily driven by human behaviour. The most significant factor is the overuse and misuse of antibiotics. In many countries, antibiotics are available without prescription, leading to their use for viral infections like the common cold, against which they are completely ineffective. In agriculture, an estimated 70% of all antibiotics sold globally are used in farm animals – not only to treat sick animals but also to promote growth and prevent disease in healthy livestock. This sub-therapeutic dosing creates a perfect breeding ground for resistant bacteria, which can then reach humans through the food chain, water run-off, and direct contact. Section D: The Consequence for Modern Medicine The implications extend far beyond difficult-to-treat pneumonia or urinary tract infections. Antibiotics are the backbone of modern medicine. Procedures such as caesarean sections, hip replacements, chemotherapy for cancer, and organ transplants rely heavily on the ability to prevent and treat bacterial infections. If these prophylactic antibiotics become ineffective, these life-saving interventions will carry unacceptable levels of risk. For example, a routine knee replacement could lead to an untreatable bone infection, forcing amputation. Cancer patients, whose immune systems are decimated by chemotherapy, would be vulnerable to otherwise harmless bacteria. As Dr. Margaret Chan, former WHO Director-General, stated, ‘A post-antibiotic era would mean the end of modern medicine as we know it.’ Section E: Global Surveillance and Action Plans In response to this threat, international bodies have launched coordinated efforts. The WHO’s Global Action Plan on Antimicrobial Resistance, adopted by member states in 2015, outlines five key objectives: to improve awareness and understanding of AMR, strengthen surveillance and research, reduce the incidence of infection through better hygiene, optimise the use of antimicrobials, and ensure sustainable investment in new medicines. The Interagency Coordination Group (IACG) has recommended the creation of an independent ‘One Health’ panel, recognising that human, animal, and environmental health are inseparable. Some countries have shown leadership: Sweden has one of the lowest antibiotic usage rates in Europe, while Australia banned the use of colistin – a last-resort antibiotic – in animal husbandry years before many other nations. Section F: The Pipeline Paradox While demand for new antibiotics is urgent, the pharmaceutical pipeline is dry. Since 1987, very few truly novel classes of antibiotics have been discovered. This is a market failure from an economic perspective. A new antibiotic is a ‘reserve’ drug – doctors will only use it in the most extreme cases to prevent resistance from developing. Consequently, the potential revenue for a new antibiotic is minuscule compared to a lucrative drug for chronic conditions like diabetes or high blood pressure. Many major pharmaceutical companies have abandoned antibiotic research altogether. To solve this, innovative funding models are being tested, such as the ‘Netflix model’ or subscription-style payments, where governments pay a fixed annual fee for access to antibiotics regardless of how many are used, decoupling profit from volume sold. Section G: Individual and Societal Solutions Tackling AMR requires a ‘One Health’ approach involving individuals, doctors, and policymakers. For the public, the message is clear: never demand antibiotics for viral illnesses, always complete the prescribed course (though some experts now argue that ‘complete the course’ may need revisiting), and practice good hand hygiene. For healthcare professionals, rapid diagnostic tests must replace the ‘just in case’ prescribing habits. For farmers, the immediate priority is to end the routine use of medically important antibiotics for growth promotion. Finally, governments must invest in water sanitation and infection control in hospitals – the front line of resistance spread. If these measures are implemented globally, the rise of resistance can be slowed, but the clock is ticking. IELTS READING QUESTIONS Questions 1-5: Matching Headings Choose the correct heading for Sections A-E from the list of headings below.
The discovery of new antibiotics has slowed dramatically because companies face a unique market problem. Unlike drugs for chronic diseases, new antibiotics are intended to be kept in (10) ______ to avoid creating resistance. This means sales volumes are low. As a result, the potential (11) ______ from an antibiotic is much smaller than that from other medications. To solve this, some propose a (12) ______ system where governments pay a set fee for (13) ______ to antibiotics, regardless of how much is used. Reading Time: 20 minutes Section A: A Post-Antibiotic Era
10. C (reserve) – ‘a new antibiotic is a ‘reserve’ drug’ 11. A (revenue) – ‘the potential revenue for a new antibiotic is minuscule’ 12. D (subscription) – ‘subscription-style payments’ or ‘Netflix model’ 13. E (access) – ‘pay for access to antibiotics’ However, in recent decades, this medical miracle has
14. B – Section D: ‘Cancer patients, whose immune systems are decimated… would be vulnerable to otherwise harmless bacteria.’ 15. C – Section F: ‘The potential revenue for a new antibiotic is minuscule compared to a lucrative drug for chronic conditions.’ regardless of how much is used.
